Serum IL-6 and Soluble IL-6 Receptor in Severe COVID-19 Pneumonia Treated With Tocilizumab
Clinical trial NCT04359667 · UNKNOWN
Trial details
- NCT number
- NCT04359667
- Sponsor
- University Hospital for Infectious Diseases, Croatia
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-06-16
- Primary completion
- 2021-04-16
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.